So Shaws accounts for 15-20% of total sellers. What do you expect happens to the other 80-85% of sellers?
BG is an easy target but he's not disincentivising new buyers. You can't say a potential investor would be wary of BG but uninformed of the market opportunity that imminent preclinical and clinical results may present... the problem is simply a lack of potential investors.
So Shaws accounts for 15-20% of total sellers. What do you...
-
- There are more pages in this discussion • 11,028 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
-0.075(4.46%) |
Mkt cap ! $286.2M | |||
| Open | High | Low | Value | Volume |
| $1.67 | $1.67 | $1.61 | $69.42K | 42.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 57287 | $1.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.61 | 13353 | 2 |
View Market Depth
| Last trade - 10.10am 09/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |